Proteasomal regulation of caspase-8 in cancer cell apoptosis

Michael V Fiandalo1, Steven R Schwarze, Natasha Kyprianou

  • 1Department of Molecular and Cellular Biochemistry and the Markey Cancer Center, University of Kentucky College of Medicine, Combs Cancer Research Building, 306, 800 Rose Street, Lexington, KY 40536, USA.

Insights

Proteasome inhibition reactivates apoptosis in TRAIL-resistant prostate cancer by stabilizing caspase-8. Targeting the E3 ligase involved in caspase-8 polyubiquitination offers a new therapeutic strategy for resistant tumors.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Signaling

Background:

  • Proteasome inhibition enhances TRAIL-induced apoptosis in resistant prostate cancer by stabilizing caspase-8.
  • The precise mechanisms of caspase-8 regulation, including its stability, ubiquitination, and trafficking, remain incompletely understood in the context of proteasome inhibition and TRAIL resistance.

Purpose of the Study:

  • To investigate the role of proteasome inhibition in caspase-8 stability, ubiquitination, trafficking, and activation in cancer cells.
  • To explore the therapeutic potential of targeting caspase-8 regulation in TRAIL-resistant cancers.

Main Methods:

  • Utilized caspase-8 deficient neuroblastoma (NB7) cells reconstituted with non-cleavable caspase-8 mutants.
  • Employed GST-TRAIL and proteasome inhibitors for apoptosis induction.
  • Performed subcellular fractionation to analyze caspase-8 activity.
  • Investigated caspase-8 polyubiquitination in LNCaP human prostate cancer cells.

Main Results:

  • Non-cleavable caspase-8 mutants induced apoptosis similarly to wild-type caspase-8 upon proteasome inhibition and GST-TRAIL treatment.
  • Caspase-8 polyubiquitination was observed after TRAIL stimulation and processing in LNCaP cells.
  • Caspase-8 activity was detected in both cytosolic and plasma membrane fractions.

Conclusions:

  • Proteasome inhibition stabilizes caspase-8, reactivating the extrinsic apoptosis pathway in resistant cancer cells.
  • Identifying the E3 ligase responsible for caspase-8 polyubiquitination presents a novel therapeutic target.
  • Combined inhibition of this E3 ligase with TRAIL may restore apoptosis signaling in resistant tumors, holding therapeutic significance.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...